261 related articles for article (PubMed ID: 28440015)
1. Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.
Persson L; Harila-Saari A; Hed Myrberg I; Heyman M; Nilsson A; Ranta S
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28440015
[TBL] [Abstract][Full Text] [Related]
2. Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia.
Raja RA; Schmiegelow K; Sørensen DN; Frandsen TL
Pediatr Blood Cancer; 2017 Jan; 64(1):32-38. PubMed ID: 27555294
[TBL] [Abstract][Full Text] [Related]
3. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
4. Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemia.
Zawitkowska J; Lejman M; Zaucha-Prażmo A; Sekuła N; Greczkowska-Chmiel T; Drabko K
Transfus Apher Sci; 2019 Oct; 58(5):634-637. PubMed ID: 31515171
[TBL] [Abstract][Full Text] [Related]
5. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
Finch ER; Smith CA; Yang W; Liu Y; Kornegay NM; Panetta JC; Crews KR; Molinelli AR; Cheng C; Pei D; Ramsey LB; Karol SE; Inaba H; Sandlund JT; Metzger M; Evans WE; Jeha S; Pui CH; Relling MV
Pediatr Blood Cancer; 2020 Jan; 67(1):e28040. PubMed ID: 31612640
[TBL] [Abstract][Full Text] [Related]
6. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
7. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe hypertriglyceridemia associated with accidental pegylated asparaginase push in a child with relapsed acute lymphoblastic leukemia.
Malbora B; Avci Z; Ozbek N
Drug Chem Toxicol; 2012 Oct; 35(4):463-6. PubMed ID: 22149271
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
[TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
11. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
[TBL] [Abstract][Full Text] [Related]
12. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Parsons SK; Skapek SX; Neufeld EJ; Kuhlman C; Young ML; Donnelly M; Brunzell JD; Otvos JD; Sallan SE; Rifai N
Blood; 1997 Mar; 89(6):1886-95. PubMed ID: 9058708
[TBL] [Abstract][Full Text] [Related]
13. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
14. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.
Mitchell L; Andrew M; Hanna K; Abshire T; Halton J; Wu J; Anderson R; Cherrick I; Desai S; Mahoney D; McCusker P; Chait P; Abdolell M; de Veber G; Mikulis D
Thromb Haemost; 2003 Aug; 90(2):235-44. PubMed ID: 12888870
[TBL] [Abstract][Full Text] [Related]
15. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
16. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.
Wolthers BO; Frandsen TL; Baruchel A; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grell K; Inaba H; Kovacs G; Liang DC; Mateos M; Mondelaers V; Möricke A; Ociepa T; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Vrooman LM; Yano M; Zapotocka E; Schmiegelow K;
Lancet Oncol; 2017 Sep; 18(9):1238-1248. PubMed ID: 28736188
[TBL] [Abstract][Full Text] [Related]
17. [Minimal contribution of severe hypertriglyceridemia in L-asparaginase-associated pancreatitis developed in a child with acute lymphocytic leukemia].
Goto Y; Nishimura R; Nohara A; Mase S; Fujiki T; Irabu H; Kuroda R; Araki R; Ikawa Y; Maeba H; Yachie A
Rinsho Ketsueki; 2016 Aug; 57(8):994-8. PubMed ID: 27599414
[TBL] [Abstract][Full Text] [Related]
18. PEG-asparaginase induced severe hypertriglyceridemia.
Galindo RJ; Yoon J; Devoe C; Myers AK
Arch Endocrinol Metab; 2016 Apr; 60(2):173-7. PubMed ID: 26331232
[TBL] [Abstract][Full Text] [Related]
19. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
[TBL] [Abstract][Full Text] [Related]
20. The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
Tong WH; Pieters R; de Groot-Kruseman HA; Hop WC; Boos J; Tissing WJ; van der Sluis IM
Haematologica; 2014 Nov; 99(11):1716-21. PubMed ID: 25150254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
